FCM
GILD icon

Fourpath Capital Management’s Gilead Sciences GILD Stock Holding History

Fourpath Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,248
Closed -$521K – 229
2025
Q4 		$521K Sell
4,248
-999
-19% -$121K 0.07% 149
2025
Q3 		$582K Sell
5,247
-1,531
-23% -$174K 0.08% 137
2025
Q2 		$751K Sell
6,778
-3,645
-35% -$388K 0.12% 109
2025
Q1 		$1.17M Sell
10,423
-2,847
-21% -$294K 0.2% 84
2024
Q4 		$1.23M Sell
13,270
-1,874
-12% -$169K 0.23% 83
2024
Q3 		$1.27M Buy
15,144
+2,407
+19% +$184K 0.23% 82
2024
Q2 		$874K Buy
12,737
+1,644
+15% +$110K 0.65% 29
2024
Q1 		$813K Buy
11,093
+4,563
+70% +$351K 0.56% 37
2023
Q4 		$529K Sell
6,530
-210
-3% -$16.3K 0.36% 61
2023
Q3 		$505K Buy
6,740
+1,081
+19% +$83.1K 0.38% 65
2023
Q2 		$436K Sell
5,659
-3,523
-38% -$281K 0.53% 58
2023
Q1 		$762K Sell
9,182
-8,422
-48% -$698K 0.53% 43
2022
Q4 		$1.51M Sell
17,604
-3,195
-15% -$253K 1.1% 18
2022
Q3 		$1.28M Buy
20,799
+15
+0.1% +$946 0.88% 24
2022
Q2 		$1.28M Buy
20,784
+2,739
+15% +$170K 0.8% 23
2022
Q1 		$1.07M Buy
18,045
+3,035
+20% +$194K 0.43% 41
2021
Q4 		$1.09M Buy
+15,010
New +$1.03M 0.42% 43

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fourpath Capital Management's GILD Position: Q1 2026 in Review

Fourpath Capital Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 4,248 shares — an estimated $521K sold.

Fourpath Capital Management first reported a position in GILD in Q4 2021 and held it in 17 quarters. The position peaked at $1.51M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Fourpath Capital Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Fourpath Capital Management sold 4,248 Gilead Sciences shares in Q1 2026, an estimated $521K.
  • Fourpath Capital Management first reported a position in Gilead Sciences in Q4 2021 and held it in 17 quarters.
  • Fourpath Capital Management's Gilead Sciences position peaked at $1.51M in Q4 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Fourpath Capital Management's 13F filing for Q1 2026, filed 1 May 2026.